These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25117407)

  • 1. Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.
    DeNicola M; Du J; Wang Z; Yano N; Zhang L; Wang Y; Qin G; Zhuang S; Zhao TC
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E630-43. PubMed ID: 25117407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
    Du J; Zhang L; Wang Z; Yano N; Zhao YT; Wei L; Dubielecka-Szczerba P; Liu PY; Zhuang S; Qin G; Zhao TC
    Am J Physiol Cell Physiol; 2016 Feb; 310(4):C270-83. PubMed ID: 26739490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodelling.
    Robinson E; Tate M; Lockhart S; McPeake C; O'Neill KM; Edgar KS; Calderwood D; Green BD; McDermott BJ; Grieve DJ
    Cardiovasc Diabetol; 2016 Apr; 15():65. PubMed ID: 27079193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
    Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
    Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 and exendin-4: not simply two of a kind.
    Nguyen TD; Doenst T
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E184. PubMed ID: 25593282
    [No Abstract]   [Full Text] [Related]  

  • 7. Exendin-4 pretreated adipose derived stem cells are resistant to oxidative stress and improve cardiac performance via enhanced adhesion in the infarcted heart.
    Liu J; Wang H; Wang Y; Yin Y; Wang L; Liu Z; Yang J; Chen Y; Wang C
    PLoS One; 2014; 9(6):e99756. PubMed ID: 24915574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix.
    Robinson E; Cassidy RS; Tate M; Zhao Y; Lockhart S; Calderwood D; Church R; McGahon MK; Brazil DP; McDermott BJ; Green BD; Grieve DJ
    Basic Res Cardiol; 2015 Mar; 110(2):20. PubMed ID: 25725809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 inhibits structural remodeling and improves Ca
    Chen J; Wang D; Wang F; Shi S; Chen Y; Yang B; Tang Y; Huang C
    Peptides; 2017 Apr; 90():69-77. PubMed ID: 28242257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by exenatide: A novel mechanism via improving mitochondrial function involving the GLP-1 receptor/cAMP/PKA pathway.
    Chang G; Liu J; Qin S; Jiang Y; Zhang P; Yu H; Lu K; Zhang N; Cao L; Wang Y; Li Y; Zhang D
    Int J Mol Med; 2018 Mar; 41(3):1693-1703. PubMed ID: 29286061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction.
    Kyhl K; Lønborg J; Hartmann B; Kissow H; Poulsen SS; Ali HE; Kjær A; Dela F; Engstrøm T; Treiman M
    Peptides; 2017 Jul; 93():1-12. PubMed ID: 28460895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 receptor expression after myocardial infarction: Imaging study using
    Ståhle M; Kytö V; Kiugel M; Liljenbäck H; Metsälä O; Käkelä M; Li XG; Oikonen V; Saukko P; Nuutila P; Knuuti J; Roivainen A; Saraste A
    J Nucl Cardiol; 2020 Dec; 27(6):2386-2397. PubMed ID: 30547299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury.
    Gao H; Kiesewetter DO; Zhang X; Huang X; Guo N; Lang L; Hida N; Wang H; Wang H; Cao F; Niu G; Chen X
    J Nucl Med; 2012 Dec; 53(12):1960-8. PubMed ID: 23139087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis.
    Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Benedetti A
    Gut; 2009 Jul; 58(7):990-7. PubMed ID: 18829977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.
    Basalay MV; Mastitskaya S; Mrochek A; Ackland GL; Del Arroyo AG; Sanchez J; Sjoquist PO; Pernow J; Gourine AV; Gourine A
    Cardiovasc Res; 2016 Dec; 112(3):669-676. PubMed ID: 27702763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.
    Sun Z; Tong G; Kim TH; Ma N; Niu G; Cao F; Chen X
    Theranostics; 2015; 5(3):240-50. PubMed ID: 25553112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exendin-4 Ameliorates Cardiac Remodeling in Experimentally Induced Myocardial Infarction in Rats by Inhibiting PARP1/NF-κB Axis in A SIRT1-Dependent Mechanism.
    Eid RA; Alharbi SA; El-Kott AF; Eleawa SM; Zaki MSA; El-Sayed F; Eldeen MA; Aldera H; Al-Shudiefat AAS
    Cardiovasc Toxicol; 2020 Aug; 20(4):401-418. PubMed ID: 32193876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
    Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
    Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.